cordycepin has been researched along with Colonic Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, K; Liu, Y; Zhang, Z; Zheng, Z | 1 |
| Deng, Q; Fang, C; Li, X; Li, Y; Xi, Q; Zhang, J; Zhang, R | 1 |
| Alhakamy, NA; Fahmy, UA | 1 |
| Aminah, FSD; Arai, M; Azhari, M; Julianti, E; Kimishima, A; Lin, J; Putra, MY; Singgih, M | 1 |
| Debnath, T; Kim, SK; Lee, SY; Lim, BO | 1 |
| Jung, KH; Kim, WJ; Lee, SJ; Moon, GS; Moon, SK | 1 |
6 other study(ies) available for cordycepin and Colonic Neoplasms
| Article | Year |
|---|---|
Cordycepin inhibits colon cancer proliferation by suppressing MYC expression.
Topics: Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Deoxyadenosines; Humans; MicroRNAs | 2022 |
Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression.
Topics: Animals; CD47 Antigen; Cell Line, Tumor; Colonic Neoplasms; Deoxyadenosines; Mice; Phagocytosis; Tumor Microenvironment | 2022 |
Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation.
Topics: Apoptosis; Cell Survival; Colonic Neoplasms; Deoxyadenosines; HCT116 Cells; Humans | 2022 |
Cytotoxic activity of cordycepin produced by marine-derived fungus Emericella sp. against HT29 human colon cancer cell lines.
Topics: Antineoplastic Agents; Aspergillus; Cell Line, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Emericella; Fungi; Humans; Luciferases; Molecular Structure | 2023 |
Anti-cancer effect and apoptosis induction of cordycepin through DR3 pathway in the human colonic cancer cell HT-29.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Colonic Neoplasms; Deoxyadenosines; G1 Phase; HT29 Cells; Humans; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor, Member 25; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxyadenosines; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; G2 Phase; Humans; Immunoprecipitation; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; RNA, Small Interfering | 2010 |